Simplified Chinese
scroll down
06
2019-08
Since the enactment of the Vaccine Administration Law, what impact will it have on China’s domestic vaccine industry? How are vaccine manufacturers preparing to comply with this new legislation? Recently, Miao Xiang, Secretary of the Board of Kangtai Biological, and Zhu Zhengyu, Head of Quality, were interviewed by CCTV’s Finance Channel. They outlined the company’s active participation in drafting the law, as well as specific measures to continuously enhance quality‑control standards and advance the development of innovative vaccine products. The program aired at 14:00 on July 31. https://mp.weixin.qq.com/s/-51NzRBQWkx2yGlrjhzIfQ
23
2019-07
Kangtai Biological has been named to the 2018 Top 10 Chinese Biopharmaceutical Companies list.
On July 15, the “2018 China Top 100 Pharmaceutical Companies Series Rankings,” compiled by the Expert Committee of the China Top 100 Pharmaceutical Companies List, were released. Kangtai Biological ranked 7th on the “Top 20 Chinese Biopharmaceutical Enterprises (including blood products, vaccines, insulin, etc.)” list.
18
2019-07
Recently, the Vaccine Administration Law was adopted at the 11th Meeting of the Standing Committee of the 13th National People’s Congress. This marks the first dedicated legislation in China’s vaccine‑administration field, and the law will officially come into force on December 1, 2019.
03
2019-07
On June 25, 2019, the signing ceremony for the design contract of Minhai Biotechnology’s international vaccine industrial base construction project was held in the company’s First Conference Room. The ceremony was chaired by Vice President Xiao Qiyou. Attending the event were Company Chairman Du Weimin, General Manager Zheng Haifa, Executive Vice President Liu Jiankai, and other senior leaders, along with Deputy General Manager Liu Zhongwen of the China Aviation Planning & Design Research Institute, Director Wei Shaohui of the Institute of Pharmaceutical Engineering Design under the Institute, and Deputy Director Zhang Wei, among other officials.
26
2019-06
On June 21, 2019, a delegation including Roland Walter Sutter, Coordinator of the World Health Organization’s Polio Eradication Office; Carolyn Sein, Technical Officer at the same office; Mark Steven Oberste, Head of the Polio Laboratory at the U.S. Centers for Disease Control and Prevention; and Zuo Shuyan, a senior WHO official in China, paid a visit to Minhai. General Manager Zheng Haifa and several other mid‑level and senior executives extended a warm welcome to the WHO delegation.
Contact Information
Customer Service Hotline
4001899806
Phone number
010-59613600
Official Website
Company Address
No. 35 Simiao Road and No. 25 Tianfu Street, Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District, Beijing
WeChat Official Account
0
%